A04142
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE BILL
No.
1783
Session of
2023
INTRODUCED BY VENKAT, MADDEN, MARCELL, KINSEY, PROBST, KHAN,
FREEMAN, NEILSON, HILL-EVANS, SCHLOSSBERG, DELLOSO, SANCHEZ,
HOWARD, D. WILLIAMS, STEELE, KAZEEM, JOZWIAK, CEPEDA-FREYTIZ,
BOROWSKI, PASHINSKI, HOHENSTEIN, ABNEY, A. BROWN, FLICK,
GIRAL, SHUSTERMAN, HANBIDGE, POWELL AND DALEY,
OCTOBER 24, 2023
REFERRED TO COMMITTEE ON HUMAN SERVICES, OCTOBER 24, 2023
AN ACT
Amending the act of April 14, 1972 (P.L.233, No.64), entitled
"An act relating to the manufacture, sale and possession of
controlled substances, other drugs, devices and cosmetics;
conferring powers on the courts and the secretary and
Department of Health, and a newly created Pennsylvania Drug,
Device and Cosmetic Board; establishing schedules of
controlled substances; providing penalties; requiring
registration of persons engaged in the drug trade and for the
revocation or suspension of certain licenses and
registrations; and repealing an act," further providing for
drug overdose medication.
The General Assembly of the Commonwealth of Pennsylvania
hereby enacts as follows:
Section 1. Section 13.8(a)(3) and (h) of the act of April
14, 1972 (P.L.233, No.64), known as The Controlled Substance,
Drug, Device and Cosmetic Act, amended November 3, 2022
(P.L.1984, No.135), are amended and the section is amended by
adding a subsection subsections to read:
Section 13.8. Drug Overdose Medication.--(a) The
department, in carrying out its duties under 28 Pa. Code Ch.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20